Transcripts SCYNEXIS, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-10 EDT			5-day change	1st Jan Change
5.155 ^USD	-1.62%		+1.68%	+1.89%

06-30	SCYNEXIS, Inc. Initiates Phase 1 Study of SCY-770 for Treatment of Autosomal Dominant Polycystic Kidney Disease	CI
06-30	Scynexis Initiates Phase 1 Study of SCY-770 to Treat Autosomal Dominant Polycystic Kidney Disease	MT

03-31	SCYNEXIS, Inc. - Special Call
23-03-30	SCYNEXIS, Inc. - Special Call
22-11-09	SCYNEXIS, Inc., Q3 2022 Earnings Call, Nov 09, 2022
22-10-20	SCYNEXIS, Inc. - Special Call
22-08-15	SCYNEXIS, Inc., Q2 2022 Earnings Call, Aug 15, 2022
22-05-12	SCYNEXIS, Inc., Q1 2022 Earnings Call, May 12, 2022
22-03-29	SCYNEXIS, Inc., Q4 2021 Earnings Call, Mar 29, 2022
22-02-10	SCYNEXIS, Inc. - Special Call
21-12-06	SCYNEXIS, Inc. - Special Call
21-11-10	SCYNEXIS, Inc., Q3 2021 Earnings Call, Nov 10, 2021
21-06-29	SCYNEXIS, Inc. - Analyst/Investor Day
21-06-02	SCYNEXIS, Inc. - Special Call
21-03-02	SCYNEXIS, Inc. - Special Call
20-07-02	SCYNEXIS, Inc. - Shareholder/Analyst Call
20-04-21	SCYNEXIS, Inc. - Special Call
20-01-08	SCYNEXIS, Inc. - Special Call
19-04-15	SCYNEXIS, Inc. - Special Call
18-07-10	SCYNEXIS, Inc. - Special Call
18-01-04	SCYNEXIS, Inc. - Special Call
17-04-25	SCYNEXIS, Inc. - Special Call